Evaluating the triglyceride glucose index as a predictive biomarker for osteoporosis in patients with type 2 diabetes
The TyG holds potential to serve as a prominent biomarker for the diagnosis of osteoporosis among type 2 diabetic patients in various clinical settings.
Authors
- Shiji Chen (ORCID: https://orcid.org/0000-0002-5775-2516)
- Jiheng Zhan (ORCID: https://orcid.org/0000-0002-9370-3367)
- Dongling Cai (ORCID: https://orcid.org/0000-0003-4101-2772)
- Qin Huang (ORCID: https://orcid.org/0000-0003-3388-1011)
- Qipeng Wei
- Weijun Guo (ORCID: https://orcid.org/0000-0003-0280-761X)
- Shuang Liang (ORCID: https://orcid.org/0009-0000-0019-0156)
- Zi-Hao Liu (ORCID: https://orcid.org/0009-0006-0537-6631)
Institutions
- Guangzhou University of Chinese Medicine (CN)
- Panyu Hospital of Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.3389/fendo.2025.1534232
- Citations
- 6
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 10.33